Penobscot Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-6,530
| Closed | -$300K | – | 189 |
|
|
2016
Q3 | $300K | Sell |
6,530
-300
| -4% | -$13.8K | 0.11% | 148 |
|
|
2016
Q2 | $343K | Sell |
6,830
-80
| -1% | -$4.02K | 0.12% | 140 |
|
|
2016
Q1 | $370K | Hold |
6,910
| – | – | 0.14% | 131 |
|
|
2015
Q4 | $454K | Hold |
6,910
| – | – | 0.14% | 122 |
|
|
2015
Q3 | $390K | Sell |
6,910
-460
| -6% | -$26K | 0.13% | 137 |
|
|
2015
Q2 | $436K | Hold |
7,370
| – | – | 0.14% | 137 |
|
|
2015
Q1 | $459K | Hold |
7,370
| – | – | 0.15% | 131 |
|
|
2014
Q4 | $424K | Hold |
7,370
| – | – | 0.13% | 131 |
|
|
2014
Q3 | $396K | Sell |
7,370
-100
| -1% | -$5.37K | 0.13% | 126 |
|
|
2014
Q2 | $392K | Buy |
7,470
+1,900
| +34% | +$99.7K | 0.13% | 127 |
|
|
2014
Q1 | $294K | Sell |
5,570
-140
| -2% | -$7.39K | 0.1% | 142 |
|
|
2013
Q4 | $229K | Sell |
5,710
-1,430
| -20% | -$57.4K | 0.08% | 157 |
|
|
2013
Q3 | $270K | Hold |
7,140
| – | – | 0.11% | 140 |
|
|
2013
Q2 | $280K | Buy |
+7,140
| New | +$280K | 0.12% | 128 |
|